Association of brain network dynamics with plasma biomarkers in subjective memory complainers-Reference-Cited by-同舟云学术

Association of brain network dynamics with plasma biomarkers in subjective memory complainers

Published:2020-04 Issue: Volume:88 Page:83-90
ISSN:0197-4580
Container-title:Neurobiology of Aging
language:en
Short-container-title:Neurobiology of Aging

Author:

Chiesa Patrizia A.,Houot Marion,Vergallo Andrea,Cavedo Enrica,Lista Simone,Potier Marie Claude,Zetterberg Henrik,Blennow Kaj,Vanmechelen Eugeen^ORCID,De Vos Ann,Dubois Bruno,Hampel Harald

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Developmental Biology,Neurology (clinical),Aging,General Neuroscience

Reference60 articles.

1. Partial least squares methods: partial least squares correlation and partial least square regression;Abdi;Methods Mol. Biol.,2013

2. Functional changes in the language network in response to increased amyloid β deposition in cognitively intact older adults;Adamczuk;Cereb. Cortex.,2016

3. The role of astroglia in Alzheimer’s disease: pathophysiology and clinical implications;Arranz;Lancet Neurol.,2019

4. Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer’s disease and other neurodegenerative diseases;Baldacci;Expert Rev. Proteomics,2017

5. Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer’s disease;Baldacci;Alzheimers Dement.,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological Mechanism-based Neurology and Psychiatry: a BACE1/2 and Downstream Pathway Model;Current Neuropharmacology;2021-12-01

2. Association of plasma Aβ40/Aβ42 ratio and brain Aβ accumulation: testing a whole-brain PLS-VIP approach in individuals at risk of Alzheimer's disease;Neurobiology of Aging;2021-11

3. The β-Secretase BACE1 in Alzheimer’s Disease;Biological Psychiatry;2021-04

4. Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery;Neuropharmacology;2021-03